6NMB
Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 80 |
| Detector technology | CCD |
| Collection date | 2017-09-27 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.9537 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 73.043, 65.446, 111.136 |
| Unit cell angles | 90.00, 97.42, 90.00 |
Refinement procedure
| Resolution | 48.560 - 2.300 |
| R-factor | 0.2233 |
| Rwork | 0.221 |
| R-free | 0.27120 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 2vnt |
| RMSD bond length | 0.017 |
| RMSD bond angle | 1.845 |
| Data reduction software | XDS |
| Data scaling software | SCALA |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 48.560 | 2.420 |
| High resolution limit [Å] | 2.300 | 2.300 |
| Rmeas | 0.226 | 0.971 |
| Rpim | 0.087 | 0.439 |
| Number of reflections | 42244 | |
| <I/σ(I)> | 5.3 | |
| Completeness [%] | 90.0 | |
| Redundancy | 6.6 | |
| CC(1/2) | 0.995 | 0.817 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 8.5 | 293 | 0.03 M sodium nitrate, 0.03 M sodium phosphate, 0.03 M ammonium sulfate, 0.1 M Tris bicine, 25% v/v PEG500, 10% v/v PEG20000 |






